BACKGROUND: Cellular and animal studies suggest that hypercholesterolemia contributes to Alzheimer disease (AD). However, the relationship between cholesterol and dementia at the population level is less clear and may vary over the lifespan. METHODS: The Prospective Population Study of Women, consisting of 1,462 women without dementia aged 38-60 years, was initiated in 1968-1969 in Gothenburg, Sweden. Follow-ups were conducted in 1974-1975, 1980-1981, 1992-1993, and 2000-2001. All-cause dementia was diagnosed according to DSM-III-R criteria and AD according to National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria. Cox proportional hazards regression examined baseline, time-dependent, and change in cholesterol levels in relation to incident dementia and AD among all participants. Analyses were repeated among participants who survived to the age of 70 years or older and participated in the 2000-2001 examination. RESULTS: Higher cholesterol level in 1968 was not associated with an increased risk of AD (highest vs lowest quartile: hazard ratio [HR] 2.82, 95% confidence interval [CI] 0.94-8.43) among those who survived to and participated in the 2000-2001 examination. While there was no association between cholesterol level and dementia when considering all participants over 32 years, a time-dependent decrease in cholesterol over the follow-up was associated with an increased risk of dementia (HR 2.35, 95% CI 1.22-4.58). CONCLUSION: These data suggest that midlife cholesterol level is not associated with an increased risk of AD. However, there may be a slight risk among those surviving to an age at risk for dementia. Declining cholesterol levels from midlife to late life may better predict AD risk than levels obtained at one timepoint prior to dementia onset. Analytic strategies examining this and other risk factors across the lifespan may affect interpretation of results.
BACKGROUND: Cellular and animal studies suggest that hypercholesterolemia contributes to Alzheimer disease (AD). However, the relationship between cholesterol and dementia at the population level is less clear and may vary over the lifespan. METHODS: The Prospective Population Study of Women, consisting of 1,462 women without dementia aged 38-60 years, was initiated in 1968-1969 in Gothenburg, Sweden. Follow-ups were conducted in 1974-1975, 1980-1981, 1992-1993, and 2000-2001. All-cause dementia was diagnosed according to DSM-III-R criteria and AD according to National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria. Cox proportional hazards regression examined baseline, time-dependent, and change in cholesterol levels in relation to incident dementia and AD among all participants. Analyses were repeated among participants who survived to the age of 70 years or older and participated in the 2000-2001 examination. RESULTS: Higher cholesterol level in 1968 was not associated with an increased risk of AD (highest vs lowest quartile: hazard ratio [HR] 2.82, 95% confidence interval [CI] 0.94-8.43) among those who survived to and participated in the 2000-2001 examination. While there was no association between cholesterol level and dementia when considering all participants over 32 years, a time-dependent decrease in cholesterol over the follow-up was associated with an increased risk of dementia (HR 2.35, 95% CI 1.22-4.58). CONCLUSION: These data suggest that midlife cholesterol level is not associated with an increased risk of AD. However, there may be a slight risk among those surviving to an age at risk for dementia. Declining cholesterol levels from midlife to late life may better predict AD risk than levels obtained at one timepoint prior to dementia onset. Analytic strategies examining this and other risk factors across the lifespan may affect interpretation of results.
Authors: K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann Journal: Proc Natl Acad Sci U S A Date: 2001-04-10 Impact factor: 11.205
Authors: C Bengtsson; G Blohmé; L Hallberg; T Hällström; B Isaksson; K Korsan-Bengtsen; G Rybo; E Tibblin; G Tibblin; H Westerberg Journal: Acta Med Scand Date: 1973-04
Authors: L M Refolo; M A Pappolla; J LaFrancois; B Malester; S D Schmidt; T Thomas-Bryant; G S Tint; R Wang; M Mercken; S S Petanceska; K E Duff Journal: Neurobiol Dis Date: 2001-10 Impact factor: 5.996
Authors: L M Refolo; B Malester; J LaFrancois; T Bryant-Thomas; R Wang; G S Tint; K Sambamurti; K Duff; M A Pappolla Journal: Neurobiol Dis Date: 2000-08 Impact factor: 5.996
Authors: S Kalmijn; D Foley; L White; C M Burchfiel; J D Curb; H Petrovitch; G W Ross; R J Havlik; L J Launer Journal: Arterioscler Thromb Vasc Biol Date: 2000-10 Impact factor: 8.311
Authors: Miia Kivipelto; Eeva-Liisa Helkala; Mikko P Laakso; Tuomo Hänninen; Merja Hallikainen; Kari Alhainen; Susan Iivonen; Arto Mannermaa; Jaakko Tuomilehto; Aulikki Nissinen; Hilkka Soininen Journal: Ann Intern Med Date: 2002-08-06 Impact factor: 25.391
Authors: M A Pappolla; T K Bryant-Thomas; D Herbert; J Pacheco; M Fabra Garcia; M Manjon; X Girones; T L Henry; E Matsubara; D Zambon; B Wolozin; M Sano; F F Cruz-Sanchez; L J Thal; S S Petanceska; L M Refolo Journal: Neurology Date: 2003-07-22 Impact factor: 9.910
Authors: Zaldy Sy Tan; Sudha Seshadri; Alexa Beiser; Peter W F Wilson; Douglas P Kiel; Michael Tocco; Ralph B D'Agostino; Philip A Wolf Journal: Arch Intern Med Date: 2003-05-12
Authors: Jeannie-Marie S Leoutsakos; Alexandra L Bartlett; Sarah N Forrester; Constantine G Lyketsos Journal: Alzheimers Dement Date: 2013-08-15 Impact factor: 21.566
Authors: Mary Ganguli; Bo Fu; Beth E Snitz; Frederick W Unverzagt; David A Loewenstein; Tiffany F Hughes; Chung-Chou H Chang Journal: Alzheimer Dis Assoc Disord Date: 2014 Jan-Mar Impact factor: 2.703
Authors: E Candeias; A I Duarte; I Sebastião; M A Fernandes; A I Plácido; C Carvalho; S Correia; R X Santos; R Seiça; M S Santos; C R Oliveira; P I Moreira Journal: Mol Neurobiol Date: 2016-10-11 Impact factor: 5.590
Authors: Melinda C Power; Andreea Rawlings; A Richey Sharrett; Karen Bandeen-Roche; Josef Coresh; Christie M Ballantyne; Yashashwi Pokharel; Erin D Michos; Alan Penman; Alvaro Alonso; David Knopman; Thomas H Mosley; Rebecca F Gottesman Journal: Alzheimers Dement Date: 2017-09-12 Impact factor: 21.566
Authors: Zachary A Marcum; Rod Walker; Jennifer F Bobb; Mo-Kyung Sin; Shelly L Gray; James D Bowen; Wayne McCormick; Susan M McCurry; Paul K Crane; Eric B Larson Journal: J Am Geriatr Soc Date: 2018-10-05 Impact factor: 5.562